Literature DB >> 8176092

Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator.

C D Swerdlow1, P S Chen, R M Kass, J R Allard, C T Peter.   

Abstract

OBJECTIVES: This study was conducted to evaluate criteria for discrimination of ventricular tachycardia from atrial fibrillation and sinus tachycardia in a tiered-therapy cardioverter-defibrillator (Medtronic PCD).
BACKGROUND: Interval stability algorithms discriminate ventricular tachycardia from atrial fibrillation. Onset algorithms discriminate ventricular tachycardia from sinus tachycardia. Neither has been validated clinically.
METHODS: The stability criterion requires that a ventricular tachycardia interval not vary from any of the three previous intervals by more than the programmable stability value. The onset criterion detects initiation of ventricular tachycardia only if the ratio of an interval to the mean of four previous intervals is less than a programmed onset ratio and either the second or third preceding interval exceeds the ventricular tachycardia detection interval. We evaluated these criteria in 100 patients at electrophysiologic study and exercise testing (65 patients) and during a mean (+/- SD) follow-up of 16.2 +/- 7.9 months. The PCDs were programmed to tiered therapy in 54 patients. In the remaining 46 patients, the PCD's memory for detected ventricular tachycardia was used to study the specificity of the chosen onset criterion for rejecting sinus tachycardia. We used stored intervals preceding appropriate (n = 99) and inappropriate (n = 54) detections to test a new onset criterion that was less sensitive to a single index interval.
RESULTS: Programmed stability of 40 ms decreased detection of induced atrial fibrillation by 95% (20 patients), paroxysmal atrial fibrillation by 95% (6 patients) and chronic atrial fibrillation by 99% (9 patients); all episodes of spontaneous (n = 877) and induced (n = 339) ventricular tachycardia were detected. A programmed onset ratio of 87% rejected sinus acceleration (98%) but caused underdetection of 0.5% of ventricular tachycardias. The onset criterion permitted inappropriate detection of premature ventricular complexes during sinus tachycardia, but the new criterion reduced these inappropriate detections by 98%.
CONCLUSIONS: The PCD's onset and stability criteria reduced inappropriate detection of atrial fibrillation and sinus acceleration while detecting 99.5% of ventricular tachycardias.

Entities:  

Mesh:

Year:  1994        PMID: 8176092     DOI: 10.1016/0735-1097(94)90376-x

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  20 in total

1.  Inappropriate implantable defibrillator discharge caused by a retained pacemaker lead fragment.

Authors:  L Lickfett; C Wolpert; W Jung; S Spehl; L Pizzulli; B Esmailzadeh; B Lüderitz
Journal:  J Interv Card Electrophysiol       Date:  1999-07       Impact factor: 1.900

Review 2.  Implantable dual-chamber cardioverter-defibrillator-pacemaker.

Authors:  D Pfeiffer; M Mende; A Hagendorff
Journal:  Curr Cardiol Rep       Date:  2000-07       Impact factor: 2.931

3.  Evaluation of a programming algorithm for the third tachycardia zone in a fourth-generation implantable cardioverter-defibrillator.

Authors:  J J Neglia; R B Krol; I Giorgberidze; P Mathew; C Lewis; A N Munsif; S Saksena
Journal:  J Interv Card Electrophysiol       Date:  1997-02       Impact factor: 1.900

Review 4.  Overview of implantable cardioverter defibrillator and cardiac resynchronisation therapy in heart failure management.

Authors:  Pow-Li Chia; David Foo
Journal:  Singapore Med J       Date:  2016-07       Impact factor: 1.858

Review 5.  Device Management in Heart Failure.

Authors:  Brett G Angel; Heath Saltzman; Luke S Kusmirek
Journal:  Curr Cardiol Rep       Date:  2017-09-25       Impact factor: 2.931

6.  Beta-blocker therapy is associated with a lower incidence of syncope due to fast ventricular tachycardias among implantable cardioverter-defibrillator patients with left ventricular dysfunction: results from a multicenter study.

Authors:  Javier Jiménez-Candil; Ignasi Anguera; Olga Durán; Jesús Hernández; Javier Fernández-Portales; José Luis Moríñigo; Ana Martín; Paolo Dallaglio; Loreto Bravo; Andrea di Marco; Pedro Luis Sánchez
Journal:  J Interv Card Electrophysiol       Date:  2018-03-20       Impact factor: 1.900

Review 7.  Should all implantable cardioverter defibrillators for ventricular arrhythmias be dual-chamber devices?

Authors:  K L Lee; C P Lau
Journal:  Curr Cardiol Rep       Date:  2001-11       Impact factor: 2.931

8.  Optimal Programming of ICDs for Prevention of Appropriate and Inappropriate Shocks.

Authors:  Ronald Lo; Amin Al-Ahmad; Henry Hsia; Paul C Zei; Paul J Wang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-09

Review 9.  Sensing and detection in Medtronic implantable cardioverter defibrillators.

Authors:  Mark L Brown; Charles D Swerdlow
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2016-09-08

10.  [New algorithms for discrimination between supraventricular and ventricular tachyarrhythmias in patients with implantable cardioverter/defibrillator].

Authors:  J Neuzner; M Schlepper
Journal:  Herzschrittmacherther Elektrophysiol       Date:  1997-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.